A detailed history of Heritage Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Heritage Wealth Advisors holds 1,119 shares of LLY stock, worth $881,984. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,119
Previous 893 25.31%
Holding current value
$881,984
Previous $808,000 22.65%
% of portfolio
0.05%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$772.14 - $960.02 $174,503 - $216,964
226 Added 25.31%
1,119 $991,000
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $1,449 - $1,818
-2 Reduced 0.22%
893 $808,000
Q1 2024

May 08, 2024

SELL
$592.2 - $792.28 $35,532 - $47,536
-60 Reduced 6.28%
895 $696,000
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $276,775 - $326,281
-527 Reduced 35.56%
955 $556,000
Q1 2023

May 04, 2023

SELL
$310.63 - $364.82 $46,594 - $54,723
-150 Reduced 9.19%
1,482 $508,000
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $66,560 - $77,556
-207 Reduced 11.26%
1,632 $597,000
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $44,472 - $50,680
-150 Reduced 7.54%
1,839 $595,000
Q2 2022

Aug 04, 2022

SELL
$278.73 - $327.27 $27,873 - $32,727
-100 Reduced 4.79%
1,989 $645,000
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $1.73 Million - $2.15 Million
-7,380 Reduced 77.94%
2,089 $598,000
Q4 2020

Feb 01, 2021

BUY
$130.46 - $172.63 $975,840 - $1.29 Million
7,480 Added 376.07%
9,469 $1.6 Million
Q2 2020

Jul 17, 2020

BUY
$136.42 - $164.18 $240,644 - $289,613
1,764 Added 784.0%
1,989 $326,000
Q2 2020

Jul 17, 2020

SELL
$136.42 - $164.18 $240,644 - $289,613
-1,764 Reduced 88.69%
225 $326,000
Q3 2019

Oct 30, 2019

BUY
$106.79 - $116.16 $39,298 - $42,746
368 Added 22.7%
1,989 $222,000
Q2 2019

Aug 05, 2019

BUY
$110.79 - $129.32 $79,325 - $92,593
716 Added 79.12%
1,621 $0
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $77,703 - $97,115
905 New
905 $97,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Heritage Wealth Advisors Portfolio

Follow Heritage Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.